Altered Gut Microbiota and Short-Chain Fatty Acids After Vonoprazan-Amoxicillin Dual Therapy for Helicobacter pylori Eradication

The combination of vonoprazan (VPZ) and amoxicillin (VA therapy) has been shown to achieve acceptable eradication rates for Helicobacter pylori (H. pylori). Herein, our aim was to explore the short-term effect of VA therapy on the gut microbiota and short-chain fatty acids (SCFAs) using human fecal...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Yi, Xu, Xin, Ouyang, Yao-Bin, He, Cong, Li, Nian-Shuang, Xie, Chuan, Peng, Chao, Zhu, Zhen-Hua, Shu, Xu, Xie, Yong, Lu, Nong-Hua, Zhu, Yin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cellular and Infection Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9201212/
https://www.ncbi.nlm.nih.gov/pubmed/35719338
http://dx.doi.org/10.3389/fcimb.2022.881968

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9201212/
https://www.ncbi.nlm.nih.gov/pubmed/35719338
http://dx.doi.org/10.3389/fcimb.2022.881968

Ejemplares similares